MAGEA genes can promote tumor progression through various mechanisms, such as through the activation of androgen receptor (AR), p53 inactivation, and an increase in oxidative phosphorylation (OXPHOS), which is overrepresented in bladder cancer and eventually contributes to highly aggressive and metastatic disease states in bladder cancer patients. Here, TP53 is linked to urinary bladder carcinoma.